Skip to main content
×
Home

Omega-3 fatty acids and blood pressure

  • Jorge Cabo (a1), Rodrigo Alonso (a2) and Pedro Mata (a2)
Abstract

Epidemiological and clinical studies suggest that consumption of omega (ω-3) polyunsaturated fatty acids (PUFA) contributes to the reduction of cardiovascular mortality through different mechanisms including modulation of cellular metabolic functions, gene expression and beneficial effects on lipid profile or blood pressure. The aim of the study is to review the effects of ω-3 PUFA supplemented as fish oil or blue fish in blood pressure. The analysis of different studies suggests that high doses ω-3 PUFA ( ≥  3 g/day) produces a small but significant decrease in blood pressure, especially systolic blood pressure, in older and hypertensive subjects; however, the evidence is not consistent among different studies. ω-3 polyunsaturated fatty acids consumption might have a place in the control of patients with mild hypertension before starting drug treatment and of those who prefer changes of lifestyles like diet.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Omega-3 fatty acids and blood pressure
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Omega-3 fatty acids and blood pressure
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Omega-3 fatty acids and blood pressure
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Pedro Mata, fax +34-915042206, email pmata@fjd.es
References
Hide All
1 Calder PC, Dangour AD, Diekman C, Eilander A, Koletzko B, Meijer GW, Mozaffarian D, Niinikoski H, Osendarp SJ, Pietinen P, Schuit J, Uauy R (2010) Essential fats for future health. Eur J Clin Nutr. 64, Suppl. 4, S113.
2 Gebauer SK, Psota TL, Harris WS & Kris-Etherton PM (2006) n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83, Suppl. 6, 1526S1535S.
3 Ward R (1990) Familial aggregation and genetic epidemiology of blood pressure. In Hypertension, Pathophysiology, Diagnosis and Management, pp. 81100 [Laragh JH and Brenner BM, editors]. New York, NY: Raven Press.
4 Cook H & McMaster C (2002) Fatty acid desaturation and chain elongation in eukaryotes. In Biochemistry of Lipids, Lipoproteins and Membranes, 4th ed., pp. 181204 [Vance DE, editor].
5 Biscione F, Pignalberi C, Totteri A, Messina F & Altamura G (2007) Cardiovascular effects of omega-3 free fatty acids. Curr Vasc Pharmacol. 5, 163172.
6 Das U (2008) Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhytmic, anty-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 7, 37.
7 Cicero AF, Ertek S & Borghi C (2009) Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol. 7, 330337.
8 Lahoz C, Alonso R, Ordovás JM, López-Farré A, de Oya M & Mata P (1997) Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. Eur J Clin Invest. 27, 780787.
9 Fischer R, Dechend R, Qadri F, Markovic M, Feldt S, Herse F, Park JK, Gapelyuk A, Schwarz I, Zacharzowsky UB, Plehm R, Safak E, Heuser A, Schirdewan A, Luft FC, Schunck WH & Muller DN (2008) Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension. Hypertension 51, 540546.
10 Das UN (2004) Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-beta to prevent human essential hypertension. Eur J Clin Nutr. 58, 195203.
11 Engler MM, Engler MB, Pierson DM, Molteni LB & Molteni A (2003) Effects of docosahexaenoic acid on vascular pathology and reactivity in hypertension. Exp Biol Med (Maywood) 228, 299307.
12 Mozaffarian D (2007) Fish, n-3 fatty acids, and cardiovascular haemodynamics. J Cardiovasc Med. 8, Suppl. 1, S23S26.
13 Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL & Katan MB (2005) Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112, 19451952.
14 Mozaffarian D, Gottdiener JS & Siscovick DS (2006) Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol. 97, 216222.
15 McLennan PL, Barnden LR, Bridle TM, Abeywardena MY & Charnock JS (1992) Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. Cardiovasc Res. 26, 871877.
16 Appel LJ, Miller ERIII, Seidler AJ & Whelton PK (1993) Does supplementation of diet with ‘fish oil’ reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 153, 14291438.
17 Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR & Kok FJ (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 20, 14931499.
18 Hartweg J, Farmer AJ, Holman RR & Neil HA (2007) Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia 50, 250258.
19 Hartweg J, Farmera AJ, Holmanb R & Neil A (2009) Potential Impact of omega-3 Treatment on cardiovascular disease in type 2 diabetes. Curr Opin Lipidol 20, 3038.
20 Rasmussen BM, Vessby B, Uusitupa M, Berglund L, Pedersen E, Riccardi G, Rivellese AA, Tapsell LL, Hermanen K, Kanwu study group, et al. (2006) Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy Subjects. Am J Clin Nutr. 83, 221226.
21 Shah AP, Ichiuji AM, Han JK, Traina M, El-Bialy A, Meymandi SK & Wachsner RY (2007) Cardiovascular and endothelial effects of fish oil supplementation in healthy Volunteers. J Cardiovasc Pharmacol There. 12, 213219.
22 Bao DQ, Mori T, Burke V, Puddey IB & Beilin LJ (1998) Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension 32, 710717.
23 Ramel A, Pumberger C, Martinez AJ, Kiely M, Bandarra NM & Thorsdottir I (2009) Cardiovascular Risk Factors in young, overweight, and obese European adults and associations with physical activity and omega-3 index. Nutr Res. 29, 305312.
24 Gulseth HL, Gjelstad IM, Tierney BC, Shaw DI, Helal O, Hees AM, Delgado J, Leszczynska-Golabek I, Karlström B, Lovegrove J, Defoort C, Blaak EE, Lopez-Miranda J, Dembinska-Kiec A, Risérus U, Roche HM, Birkeland KI & Br Drevon CA (2010) Dietary fat and blood pressure modifications in subjects with the metabolic syndrome in the dietary intervention LIPGENE study. J Nutr. 104, 160163.
25 Cicero AF, Derosa G, Di Gregorio V, Bove M, Gaddi AV & Borghi C (2010) Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. Clin Exp Hypertens 32, 137144.
26 Micallef MA & Garg ML (2009) Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis. 204, 476482.
27 Murphy KJ, Meyer BJ, Mori TA, Burke V, Mansour J, Patch CS, Tapsell LC, Noakes M, Clifton PA, Barden A, Puddey IB, Beilin LJ & Howe PR (2007) Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular Risk factors. Br J Nutr. 97, 749757.
28 Theobald Middleaged HE, Goodall AH, Sattar N, Talbot DC, Chowienczyk PJ & Sanders TA (2007) Low-dose docosahexaenoic acid lowers diastolic blood pressure in men and women. J Nutr 137, 973978.
29 Sanders TA, Gleason K, Griffin B & Miller GJ (2006) Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6n-3) and docosapentaenoic acid (22:5n-6) on Cardiovascular Risk Factors in Healthy Men and Women. Br J Nutr 95, 525531.
30 Mori TA, Bao DQ, Burke V, Puddey IB & Beilin LJ (1999) Docosahexaenoic acid but not eicosapentaenoic Acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34, 253260.
31 Vernaglione L, Cristofano C & Chimienti S (2008) Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study. J Nephrol. 21, 99105.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 146
Total number of PDF views: 520 *
Loading metrics...

Abstract views

Total abstract views: 3654 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 20th November 2017. This data will be updated every 24 hours.